FDA updates guidance on COVID-19 convalescent plasma
The Food and Drug Administration yesterday updated its guidance and webpage on COVID-19 convalescent plasma.
The updates include recommendations on when individuals who have received an investigational COVID-19 vaccine qualify as convalescent plasma donors, and extend the period of enforcement discretion described in the guidance.
In addition, FDA yesterday posted updated information for blood establishments regarding the COVID-19 pandemic and blood donation.
Related News Articles
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…